Colombia Pharmaceuticals and Healthcare Report Q3 2012Business Monitor International
June 19, 2012
93 Pages - SKU: BMI3943233
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Colombia Prescription Drugs reports
Colombia Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: We continue to view Colombia as a promising longer-term Latin American pharmaceuticalmarket. It is currently the fifth-largest in the region, although its size ...
Antibiotics Market in Colombia to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Colombia. The study provides essential market ...
The Pharmaceutical Market: Colombia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Colombia Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor InternationalSee all reports like this >>
BMI View: Colombia’s pharmaceutical and healthcare markets will perform better than the regional average over the medium term due to its high urbanisation rate and ...
More Colombia reports
D&B Country RiskLine Report: Colombia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Colombia: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis of Colombia, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
D&B Country Report: Colombia by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
2007 Colombia Industry & Market Outlook report by Barnes ReportsSee all reports like this >>
The 2007 Colombia Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Colombia and 500+ minor industries ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports